company

BIOMAX NORGE AS

1570 DILLING

Return on Equity
80,05 %
Current Ratio
0,61
Debt-to-Equity Ratio
−0,77
Key figures (NOK)2022
Revenue70 000
Net Income−313 000
Total Assets137 000
Total Equity−391 000
Income (NOK)2022
Revenue70 000
Expenditure384 000
Operating Profit−313 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−313 000
Tax0
Net Income−313 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets137 000
Total Assets137 000
Total Retained Equity−421 000
Total Equity−391 000
Total Long-Term Debt302 000
Total Current Debt226 000
Total Equity and Debt137 000
Cash flow (NOK)2022
Sales Income70 000
Other Income0
Revenue70 000
Cost of Goods Sold164 000
Salary Costs105 000
Depreciation0
Impairment0
Expenditure384 000
Operating Profit−313 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−313 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank40 000
Total Current Assets137 000
Total Assets137 000
Total Equity−391 000
Short-Term Group Debt0
Total Long-Term Debt302 000
Creditors209 000
Unpaid Taxes4 000
Dividends0
Other Current Debt13 000
Total Current Debt226 000
Total Equity and Debt137 000
Financial indicators2022
Return on Equity80,05 %
Debt-to-Equity Ratio−0,77
Operating Profit Margin−447,14 %
Current Ratio0,61
Quick Ratio0,61
Equity Ratio−2,85
Gross Profit Margin−134,29 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English